Efficacy of pemetrexed as second-line therapy in advanced NSCLC after either treatment-free interval or maintenance therapy with gemcitabine or erlotinib in IFCT-GFPC 05-02 phase III study.

Bylicki, Olivier; Ferlay, Céline; Chouaid, Christos; Lavolé, Armelle; Barlési, Fabrice; Dubos, Cathérine; Westeel, Virginie; Créquit, Jacky; Corre, Roman; Vergnenègre, Alain; Monnet, Isabelle; Le Caer, Hervé; Fournel, Pierre; Vaylet, Fabien; Falchero, Lionel; Poudenx, Michel; Linard, Pauline; Pérol, David; Zalcman, Gérald; Pérol, Maurice

Bylicki, Olivier; Ferlay, Céline; Chouaid, Christos; Lavolé, Armelle; Barlési, Fabrice; Dubos, Cathérine; Westeel, Virginie; Créquit, Jacky; Corre, Roman; Vergnenègre, Alain; Monnet, Isabelle; Le Caer, Hervé; Fournel, Pierre; Vaylet, Fabien; Falchero, Lionel; Poudenx, Michel; Linard, Pauline; Pérol, David; Zalcman, Gérald; Pérol, Maurice.

Affiliation

Bylicki O; Hospices Civils de Lyon, Lyon, France.

J Thorac Oncol ; 8(7): 906-14, 2013 Jul.

Article in En | MEDLINE | ID: mdl-23591160

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Squamous Cell / Adenocarcinoma / Antineoplastic Combined Chemotherapy Protocols / Salvage Therapy / Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Thorac Oncol Year: 2013 Document type: Article Affiliation country: Francia Country of publication: Estados Unidos

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google